Real-time enrollment status for this plantar fibromatosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT06151197 |
| Recruiting Status | Recruiting |
| Condition | Plantar Fibromatosis |
| Phase | Clinical Trial |
| Target Enrollment | 418 participants |
| Active Locations | 63 sites in the US |
| Sponsor | Endo Pharmaceuticals |
| Last Updated on CT.gov | October 20, 2025 (Oct 20, 2025) |
As of March 2, 2026: Clinical trial NCT06151197 is currently recruiting participants. This clinical trial study for plantar fibromatosis is actively seeking new participants at 63 locations across the United States. The study is sponsored by Endo Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06151197 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06151197 was last updated Oct 20, 2025 (October 20, 2025). HelloStudys verifies this status automatically.